Critical Insights From Veru Analyst Ratings: What You Need To Know - Veru (NASDAQ:VERU)
Stay updated with breaking news from Internal Condom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MIAMI, FL, May 02, 2024 -- Veru Inc. , a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and...
MIAMI, FL, April 25, 2024 -- Veru Inc. , a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and...
MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innova...
MIAMI, FL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative...